Literature DB >> 14770413

Chiral synthesis of (2S,3S)-2-(2-morpholin-2-yl-2-phenylmethoxy)phenol.

Jaya Prabhakaran1, Vattoly J Majo, J John Mann, J S Dileep Kumar.   

Abstract

Resolution of (2RS,3RS)-2-[alpha-(2-methoxymethoxyphenoxy)phenylmethyl]morpholine, 11, with (+) mandelic acid led to the formation of (+)-(2S,3S)-2-[alpha-(2-methoxymethoxyphenoxy)phenyl methyl] morpholine (11a). Compound 11 was synthesized in seven steps from (2RS,3RS)-cinnamyl alcohol-2,3-epoxide (4), with an overall yield of 17%. Cleavage of the methoxymethyl group of the Fmoc derivative 12 with catalytic amounts of p-toluenesulfonic acid in methanol afforded (+)-(2S,3S)-2-(2-morpholin-2-yl-2-phenylmethoxy)phenol 2. The synthetic utility as well as the configuration of compound 2 has been demonstrated by converting (S,S)-2-(2-morpholin-2-yl-2-phenylmethoxy)phenol 2 to (2S,3S)-2-[alpha-(2-ethoxyphenoxy)phenylmethyl]morpholine (1) and (2S,3S)-2-(2-methoxyphenoxy) benzyl)morpholine (16), two potential norepinephrine reuptake inhibitors under clinical evaluation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770413     DOI: 10.1002/chir.20004

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.

Authors:  Alin J Severance; Matthew S Milak; J S Dileep Kumar; Jaya Prabhakaran; Vattoly J Majo; Norman R Simpson; Ronald L Van Heertum; Victoria Arango; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-19       Impact factor: 9.236

2.  Enantioselective synthesis of (2R,3R)- and (2S,3S)-2- [(3-chlorophenyl)-(2-methoxyphenoxy)methyl]morpholine.

Authors:  Wayne W Harding; Matthis Hodge; Zhixia Wang; William L Woolverton; Damon Parrish; Jeffrey R Deschamps; Thomas E Prisinzano
Journal:  Tetrahedron Asymmetry       Date:  2005-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.